Dual neutrophil subsets exacerbate or suppress inflammation in tuberculosis via IL-1β or PD-L1

Author:

Doz-Deblauwe Emilie1ORCID,Bounab Badreddine1,Carreras Florence1,Fahel Julia S12ORCID,Oliveira Sergio C32,Lamkanfi Mohamed4ORCID,Le Vern Yves1,Germon Pierre1ORCID,Pichon Julien1ORCID,Kempf Florent1ORCID,Paget Christophe56,Remot Aude1ORCID,Winter Nathalie1ORCID

Affiliation:

1. INRAE, Université de Tours, Nouzilly, France

2. Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Brazil

3. Department of Immunology, University of Sao Paolo, Sao Paulo, Brazil

4. Laboratory of Medical Immunology, Department of Internal Medicine and Pediatrics, Ghent University

5. INSERM, U1100, Centre d’Étude des Pathologies Respiratoires, Tours, France

6. Faculté de Médecine, Université de Tours, Tours, France

Abstract

Neutrophils can be beneficial or deleterious during tuberculosis (TB). Based on the expression of MHC-II and programmed death ligand 1 (PD-L1), we distinguished two functionally and transcriptionally distinct neutrophil subsets in the lungs of mice infected with mycobacteria. Inflammatory [MHC-II, PD-L1lo] neutrophils produced inflammasome-dependent IL-1β in the lungs in response to virulent mycobacteria and “accelerated” deleterious inflammation, which was highly exacerbated in IFN-γR−/−mice. Regulatory [MHC-II+, PD-L1hi] neutrophils “brake” inflammation by suppressing T-cell proliferation and IFN-γ production. Such beneficial regulation, which depends on PD-L1, is controlled by IFN-γR signaling in neutrophils. The hypervirulent HN878 strain from the Beijing genotype curbed PD-L1 expression by regulatory neutrophils, abolishing the braking function and driving deleterious hyperinflammation in the lungs. These findings add a layer of complexity to the roles played by neutrophils in TB and may explain the reactivation of this disease observed in cancer patients treated with anti-PD-L1.

Funder

FEDER Centre Val de Loire

CAPES-COFECUB

Publisher

Life Science Alliance, LLC

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3